Archives of Neurology · 1973 · 86 citations · 10 references
MedicinePharmacologyPharmacotherapyClinical PharmacologyEpilepsyTherapeutic Drug MonitoringAdult EpilepsyAntiepileptic Drug MonitoringAntiepileptic PharmacologyAntiepileptic PharmacotherapySeizure DisordersSeizure ManagementAbsence Seizure PharmacotherapyEthosuximide TreatmentRefractory Epilepsy Treatment
Plasma ethosuximide level was monitored in 70 patients with absence (petit mal) seizures. Levels were linearly related to administered dose. Of 37 ambulatory patients with uncontrolled attacks, 38% (14) had levels below the 95% tolerance limit in contrast to 9% (5) of the controlled group. This difference, due to noncompliance with therapy, was eliminated by regular monitoring. Appropriate adjustment of plasma ethosuximide levels resulted in a reduction of seizures in 48% (18) of previously uncontrolled patients. Practical control of epilepsy increased from 64% (45) to 81% (57). Monitoring of plasma ethosuximide increases the effectiveness of therapy by the recognition of noncompliance and the individualization of drug requirements.
10
COMPLIANCE WITH MEDICAL REGIMENS
Mary‐'Vesta Marston · Nursing Research · 1970 · 360 citations
William G. Lennox · Journal of the American Medical Association · 1945 · 336 citations
Medicine, Neurology, Psychiatry +6
A new drug for petit mal epilepsy
Frederic T. Zimmerman, Bessie B. Burgemeister · Neurology · 1958 · 94 citations
Jean Holowach, Donald L. Thurston, James L. O′Leary · PEDIATRICS · 1962 · 90 citations
Medicine, Neurology, Pediatrics +8